A randomized trial of candidate inactivated quadrivalent influenza vaccine versus trivalent influenza vaccines in children aged 3-17 years

The Journal of Infectious Diseases
Joseph B DomachowskeVarsha Jain

Abstract

Two antigenically distinct influenza B lineages have cocirculated since 2001, yet trivalent influenza vaccines (TIVs) contain 1 influenza B antigen, meaning lineage mismatch with the vaccine is frequent. We assessed a candidate inactivated quadrivalent influenza vaccine (QIV) containing both B lineages vs TIV in healthy children aged 3-17 years. Children were randomized 1:1:1 to receive QIV or 1 of 2 TIVs (either B/Victoria or B/Yamagata lineage; N = 2738). Hemagglutination-inhibition assays were performed 28 days after 1 or 2 doses in primed and unprimed children, respectively. Immunological noninferiority of QIV vs TIV against shared strains, and superiority against alternate-lineage B strains was based on geometric mean titers (GMTs) and seroconversion rates. Reactogenicity and safety were also assessed (Clinicaltrials.gov NCT01196988). Noninferiority against shared strains and superiority against alternate-lineage B strains was demonstrated for QIV vs TIV. QIV was highly immunogenic; seroconversion rates were 91.4%, 72.3%, 70.0%, and 72.5% against A/H1N1, A/H3N2, B/Victoria, and B/Yamagata, respectively. Reactogenicity and safety of QIV was consistent with TIV. QIV vs TIV showed superior immunogenicity for the additional B ...Continue Reading

References

Jan 1, 1980·American Journal of Epidemiology·W P GlezenC Aldridge
Jan 9, 2003·JAMA : the Journal of the American Medical Association·William W ThompsonKeiji Fukuda
Jan 23, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ville PeltolaOlli Ruuskanen
Sep 21, 2004·The Journal of Infectious Diseases·Terho HeikkinenTaina Juven
Dec 16, 2005·The New England Journal of Medicine·Niranjan BhatUNKNOWN Influenza Special Investigations Team
May 9, 2006·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Ladonna K HiteFlor M Munoz
Mar 8, 2008·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Wen-Chen LiTzou-Yien Lin
Mar 19, 2011·The Journal of Infection·Susanna EspositoNicola Principi
Oct 1, 2011·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·UNKNOWN Centers for Disease Control and Prevention
Jan 19, 2012·Human Vaccines & Immunotherapeutics·Christopher S Ambrose, Myron J Levin

❮ Previous
Next ❯

Citations

Oct 8, 2013·Indian Pediatrics·V M VashishthaP Choudhury
Dec 18, 2013·The New England Journal of Medicine·Lindsey R Baden
Dec 18, 2013·The New England Journal of Medicine·Varsha K JainBruce L Innis
Jul 13, 2013·The Journal of Infectious Diseases·Raphael Dolin
Mar 22, 2014·The New England Journal of Medicine·Varsha K JainBruce L Innis
Jul 20, 2014·Advances in Pediatrics·Daniel GonzalezMichael Cohen-Wolkowiez
Dec 8, 2015·Expert Review of Vaccines·Rafik Bekkat-BerkaniBruce L Innis
Jun 23, 2015·Expert Review of Vaccines·Hans de Graaf, Saul N Faust
Apr 17, 2014·Expert Review of Pharmacoeconomics & Outcomes Research·Emma QuinnAnthony T Newall
Aug 7, 2013·Emergency Medicine Clinics of North America·Matthew B Laurens
Sep 25, 2015·American Journal of Epidemiology·Cuiling XuBenjamin J Cowling
Jun 20, 2015·Human Vaccines & Immunotherapeutics·Nicola PrincipiSusanna Esposito
Apr 23, 2015·The Journal of General Virology·Carolien E van de SandtMarine L B Hillaire
Sep 12, 2015·Future Microbiology·Carolien E van de SandtRory D de Vries
Sep 10, 2015·MMW Fortschritte der Medizin·Peter WutzlerKlaus Wahle
Aug 21, 2015·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·Z JenningsD E Dwyer
Jun 11, 2015·Der Internist·C Forstner, M W Pletz
Nov 16, 2013·Human Vaccines & Immunotherapeutics·Manika Suryadevara, Joseph B Domachowske
Jun 16, 2016·Journal of the Pediatric Infectious Diseases Society·Melissa S StockwellPhilip LaRussa
Jul 21, 2016·Human Vaccines & Immunotherapeutics·David Baxter
Aug 26, 2016·MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports·Lisa A GrohskopfJoseph S Bresee
Sep 22, 2016·Influenza and Other Respiratory Viruses·Aye M MoaChandini R MacIntyre
Jul 2, 2015·Memórias do Instituto Oswaldo Cruz·Ana Helena PerosaNancy Bellei
Apr 12, 2014·Current Opinion in Pediatrics·Carol M KaoJoseph A Bocchini
Jan 22, 2014·The Pediatric Infectious Disease Journal·David P GreenbergMichael D Decker
Aug 16, 2017·Paediatric Drugs·Aleisha J AndersonChristopher C Blyth
Apr 12, 2016·Tuberculosis and Respiratory Diseases·Jae Yeol Kim
Aug 25, 2020·Lung India : Official Organ of Indian Chest Society·Raja DharParvaiz A Koul

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT00287469

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Epigenetics Insights from Twin Studies

Find the latest research on epigenetics and twin studies here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Regulation of Vocal-Motor Plasticity

Dopaminergic projections to the basal ganglia and nucleus accumbens shape the learning and plasticity of motivated behaviors across species including the regulation of vocal-motor plasticity and performance in songbirds. Discover the latest research on the regulation of vocal-motor plasticity here.

Myocardial Stunning

Myocardial stunning is a mechanical dysfunction that persists after reperfusion of previously ischemic tissue in the absence of irreversible damage including myocardial necrosis. Here is the latest research.